IACCARINO, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 2.757
AS - Asia 1.477
SA - Sud America 883
EU - Europa 864
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.056
Nazione #
US - Stati Uniti d'America 2.682
BR - Brasile 794
SG - Singapore 577
CN - Cina 484
UA - Ucraina 227
IT - Italia 211
DE - Germania 122
HK - Hong Kong 86
VN - Vietnam 85
SE - Svezia 57
FI - Finlandia 56
GB - Regno Unito 54
IN - India 32
MX - Messico 32
KR - Corea 30
TR - Turchia 27
RU - Federazione Russa 26
CA - Canada 24
AR - Argentina 23
BD - Bangladesh 23
ZA - Sudafrica 22
EC - Ecuador 20
IQ - Iraq 20
JP - Giappone 19
NL - Olanda 19
PL - Polonia 19
BE - Belgio 15
UZ - Uzbekistan 15
PK - Pakistan 13
FR - Francia 12
CO - Colombia 11
SA - Arabia Saudita 11
MA - Marocco 10
VE - Venezuela 9
ID - Indonesia 8
KE - Kenya 8
PY - Paraguay 8
CZ - Repubblica Ceca 7
TN - Tunisia 7
ES - Italia 6
JO - Giordania 6
LT - Lituania 6
PA - Panama 6
UY - Uruguay 6
AT - Austria 5
EG - Egitto 5
KZ - Kazakistan 5
PE - Perù 5
AZ - Azerbaigian 4
BO - Bolivia 4
DZ - Algeria 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
AO - Angola 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
PT - Portogallo 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
LI - Liechtenstein 1
ML - Mali 1
NG - Nigeria 1
PH - Filippine 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
Totale 6.056
Città #
Dallas 1.313
Singapore 312
Chandler 303
Jacksonville 136
Beijing 122
Ashburn 91
Sassari 88
Hong Kong 86
Princeton 84
Nanjing 64
Ann Arbor 62
New York 50
São Paulo 47
Shanghai 44
Dearborn 37
Seoul 30
Wilmington 29
Ho Chi Minh City 27
Nanchang 27
Los Angeles 25
Belo Horizonte 22
Helsinki 22
Santa Clara 22
Boardman 21
Shenyang 21
Tianjin 20
Jinan 19
Hanoi 18
Rio de Janeiro 18
Tokyo 17
Warsaw 17
Brussels 15
Frankfurt am Main 15
Hebei 15
Johannesburg 15
Tashkent 15
Council Bluffs 14
Curitiba 14
Poplar 14
Woodbridge 14
Changsha 13
Munich 13
San Francisco 12
Stockholm 12
Orem 11
Guangzhou 10
Mexico City 10
Zhengzhou 10
Brooklyn 9
Campo Grande 9
Chicago 9
Mountain View 9
Ningbo 9
Toronto 9
Betim 8
Boston 8
Brasília 8
Cagliari 8
Campinas 8
Columbus 8
Guarulhos 8
Joinville 8
Niterói 8
Quito 8
Salvador 8
Baghdad 7
Denver 7
Dhaka 7
Guayaquil 7
Juiz de Fora 7
Norwalk 7
Pelotas 7
Porto Alegre 7
Ribeirão Preto 7
The Dalles 7
Amsterdam 6
Atlanta 6
Bragança Paulista 6
Chennai 6
Cotia 6
Haikou 6
Jeddah 6
Nairobi 6
Nuremberg 6
Osasco 6
Rome 6
Sumaré 6
Taizhou 6
Amman 5
Andover 5
Bauru 5
Buffalo 5
Canelli 5
Caracas 5
Contagem 5
Falls Church 5
Haiphong 5
Houston 5
Izmir 5
Jiaxing 5
Totale 3.766
Nome #
null 509
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 231
Prune melanoidins protect against oxidative stress and endothelial cell death 174
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors 171
ALTERATION IN VESICLE TRAFFICKING IN PARKINSON’S DISEASE: FROM PATHOLOGICAL MOLECULAR MECHANISMS TO THERAPEUTIC OPTION 169
Role of LRRK2 in the regulation of dopamine receptor trafficking. 166
Epigenetic changes associated with the expression of Amyotrophic Lateral Sclerosis (ALS) causing genes 163
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8 156
AMYOTROPHIC LATERAL SCLEROSIS AND TDP-43: AN EPIGENETIC LIAISON 154
Cyanotoxins exposure and TDP-43 physiopathology: a molecular study 142
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype 142
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis 135
Alternative splicing of pro- and anti-apoptotic genes in amyotrophic lateral sclerosis 132
Apoptotic mechanisms in mutant LRRK2-mediated cell death 131
Dual control of dopamine synthesis and release by pre- and postsynaptic dopamine D2 receptors 129
Functional analysis of TDP43: interaction with the epigenetic machinery 128
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways 127
Control of Lactotrop Proliferation by Dopamine: Essential Role of Signalling Through D2 Receptors and ERKs 124
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON DOPAMINE METABOLISM IN PC12 CELLS 124
Astroglial inhibition of NF-kappaB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) 124
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 123
Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases 123
Inhibition of receptor-dependent urokinase signalling by specific Ser to Glu substitutions 119
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities 119
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 119
Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for Amyotrophic Lateral Sclerosis (ALS) 119
Cyanobacteria, cyanotoxins, and neurodegenerative diseases: Dangerous liaisons 113
Neurobiological features of dopamine D2 receptors. Distinct functions of D2L and D2S in vivo 109
Bcl2a1 role in familial Amyotrophic Lateral Sclerosis (ALS) 108
GFP-based reporters to monitor biochemical alteration in cellular models for Amyotrophic Lateral Sclerosis 105
Role of LRRK2 in the regulation of dopamine receptor trafficking 104
Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility 98
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models 97
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity 97
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 96
Natural polyphenols for one pot green synthesis and stabilization of gold nanoparticles with antioxidant and biological activities 95
Understanding the function of dopamine D2 receptor : A knock-out animal approach 90
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease 89
LRRK2 and vesicle trafficking 86
Regulatory roles of hnRNP M and Nova-1 in the alternative splicing of the dopamine D2 receptor pre-mRNA 85
SOD1-LINKED FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS: UNDERSTANDING THE TOXIC FUNCTION OF THE MUTANT ENZYMES 85
Parkinson’s disease-related genes and lipid alteration 81
PROTEIN KINASE C-DEPENDENT IN VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST 80
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy 79
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects 78
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 72
Prune melanoidins protect endothelial cell against oxidative stress and mitochondria-mediated cell death 66
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 62
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner 54
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 28
Cyanobacteria and cyanotoxins: a long history of studies in Sardinia (Italy) 5
Totale 6.115
Categoria #
all - tutte 21.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 5 49 14 62 43 10 6
2021/2022261 23 2 7 5 2 9 8 12 36 40 27 90
2022/2023542 50 61 15 94 45 86 4 66 79 5 27 10
2023/2024218 24 13 2 8 24 35 24 5 0 11 34 38
2024/20251.665 7 8 102 49 80 65 120 315 514 262 93 50
2025/20262.414 139 400 1.094 385 244 152 0 0 0 0 0 0
Totale 6.115